Figure 2
Visualization of recurrent deletions on 9q and UPD on 13q that were present at diagnosis (indicated as D) and/or relapse (indicated as R) by dCHIP. (A) Log2 ratios of 6 patients with del(9q) at the time of diagnosis. Patients #8, #13, and #47 maintained the same deletions at both time points, whereas in patients #4, #5, and #21, del(9q) was lost. Blue indicates deleted and red indicates gained chromosomal segments. (B) Cases with UPD13q at diagnosis and relapse (n = 3), at diagnosis only (n = 1), or at relapse only (n = 7). Mutation status is indicated below the corresponding FLT3-ITD mutation: −/− no mutation; −/+, heterozygous mutation; +/+ homozygous mutation. Blue indicates homozygous (= LOH) and yellow heterozygous regions of chromosome 13 as determined by SNP profiling.

Visualization of recurrent deletions on 9q and UPD on 13q that were present at diagnosis (indicated as D) and/or relapse (indicated as R) by dCHIP. (A) Log2 ratios of 6 patients with del(9q) at the time of diagnosis. Patients #8, #13, and #47 maintained the same deletions at both time points, whereas in patients #4, #5, and #21, del(9q) was lost. Blue indicates deleted and red indicates gained chromosomal segments. (B) Cases with UPD13q at diagnosis and relapse (n = 3), at diagnosis only (n = 1), or at relapse only (n = 7). Mutation status is indicated below the corresponding FLT3-ITD mutation: −/− no mutation; −/+, heterozygous mutation; +/+ homozygous mutation. Blue indicates homozygous (= LOH) and yellow heterozygous regions of chromosome 13 as determined by SNP profiling.

Close Modal

or Create an Account

Close Modal
Close Modal